Fundraising FoxBiotech Startups
11,050 companies tagged Biotech, with their investors and founders.
Cairn Therapeutics is a biopharmaceutical company developing oncology treatments intended to address drawbacks of standard chemotherapy such as side effects, low potency, and multidrug resistance. Its lead candidate, CT-262, is based on duocarmycin drug chemistry invented by Dale Boger at Scripps Research.
0 investors
0 investors
0 investors
0 investors
0 investors
Calidi is a biotech company developing genetic medicine therapies. The page describes it as a biotech startup working in the genetic medicine field.
0 investors
A company building pharmacy infrastructure to support modern medicine, currently pre-launch. The page provides no further detail on its product or customers.
0 investors
0 investors
0 investors
Calviri is a biotechnology company developing multi-cancer blood tests and cancer vaccines for dogs and humans, based on antigens said to be shared across tumors. Its first commercial product is StageOne Plus, a canine multi-cancer, multi-stage diagnostic test, and it is also running clinical trials of preventative and therapeutic canine cancer vaccines.
0 investors
0 investors
0 investors
0 investors
0 investors
Cambridge Technologies provides veterinarians with next-generation diagnostics and custom-manufactured autogenous vaccines for production animals, including beef and dairy cattle, swine, and small ruminants. Using its "Precision Vaccinology" process, the company sequences herd samples to identify pathogens and formulates herd-specific vaccines to prevent disease and reduce antibiotic dependence.
0 investors
0 investors
Canal Biosciences develops DNA library preparation technology for next-generation sequencing, centered on its TrueLink platform and DISTAL-seq products that attach sequencing adaptors to native DNA termini without end repair to preserve template integrity. Its methods target high-precision NGS applications such as liquid biopsy, methylation sequencing, and minimal residual disease detection in cancer.
0 investors
0 investors
0 investors
0 investors
CancerVax develops cancer therapeutics using lipid nanoparticle technology in partnership with Cytiva. The company is focused on creating nanoparticle-based treatments for cancer patients.
0 investors
0 investors
Cannabinoid API Solutions distributes pharmaceutical-grade hemp-derived cannabinoid active pharmaceutical ingredients to pharmaceutical companies conducting clinical and commercial activities. The company partners with 22nd Century Group and GVB Biopharma, which manufacture isolate-form APIs including CBD, CBG, CBN, and other minor cannabinoids.
0 investors
CannapharmaRx cultivates high-quality medical and craft cannabis from a facility in Cremona, Alberta, with capacity for over 6,000 kg per year and more than 200 genetic strains across 15 brand classes. The company sells in Canada and exports to European markets such as Germany, with plans to expand into Israel.
0 investors